GeraldMaguireMD

PubMed

• 45 citations
  Olanzapine in the treatment of developmental stuttering: a double-blind, placebo-controlled trial.
  Gerald A. Maguire, Glyndon D. Riley, David L. Franklin, Michael E. Maguire, Charles T. Nguyen
  Annals of Clinical Psychiatry. 2004-04-01
• 144 citations
  Increased dopamine activity associated with stuttering.
  Joseph C. Wu, Gerald A. Maguire, Glyndon D. Riley, Angie Lee, David Keator
  Neuroreport. 1997-02-10
• 31 citations
  Management of Child and Adolescent Stuttering with Olanzapine: Three Case Reports
  Nathan Lavid, David L. Franklin, Gerald A. Maguire
  Annals of Clinical Psychiatry. 1999-12-01

Journal Articles

• Remote Synchronous, Hands-On Ultrasound Education  
  Winn S, McKeown P, Lotfipour S, Maguire GA, Youm JH, Wiechmann W, Fox JC, Telemed J E Health, 1/23/2015
• Pharmism: A Tale of Two Perspectives  
  Citrome L, Karagianis J, Maguire GA, Nierenberg AA, International Journal of Clinical Practice, 1/1/2014
• Off-Label Uses of Second-Generation Antipsychotic Drugs  
  Warren CR, Serrato JJ, Maguire GA, Taiwanese Journal of Psychiatry, 1/1/2012
• An Overview of the Diagnosis and Treatment of Stuttering  
  Maguire GA, Yeh CY, Ito BS, Journal of Experimental and Clinical Medicine, 1/1/2012
• Alleviation of Developmental Stuttering Following Deep Brain Stimulation of the Ventral Intermediate Nucleus of the Thalamus  
  Maguire GA, Ngo, J, Fonsworth PK, Doan J, Birch JA, Fineman I, American Journal of Psychiatry, 1/1/2012
• Gabapentin for the Treatment of Acquired Neurogenic Stuttering  
  Maguire G, Bird A, Annals of Clinical Psychiatry, 1/1/2012
• Asenapine in the Treatment of Stuttering  
  Maguire G, Kirsten J, Franklin D, American Journal of Psychiatry, 1/1/2011
• Stuttering Onset Associated with Streptococcal Infection: A Case to Suggest Stuttering as PANDAS  
  Maguire GA, Viele SN, Agarwal S, Handler E, Franklin D, Annals of Clinical Psychiatry, 1/1/2010
• Exploratory Randomized Clinical Study of Pagoclone in Persistent Developmental Stuttering: The EXPRESS Trial  
  Maguire G, Franklin D, Vatakis NG, Morgenshtern E, Denko T, Yaruss JS, Spotts C, Davis, L, Davis, A, Fox, P, Soni P, Blomgren M, Silverman A, Riley G, Journal of Clinical Psychopharmacology, 1/1/2010
• A Randomized Controlled Trial of the Effect of Sublingual Orally Disintegrating Olanzapine versus Oral Olanzapine on Body Mass Index: The PLATYPUS Study  
  Karagianis J, Grossman L, Landry J, Reed VA, de Haan L, Maguire GA, Hoffmann VP, Milev R, Schizophrenia Research, 1/1/2009
• Add Avoidance/Anxiety to DSM V Stuttering Criteria  
  Maguire, GA, Huang V, Huffman CS, Current Psychiatry, 1/1/2009
• Case Report of an Interaction of a Vagal Nerve Stimulation System with a Microwave Current from a Body Fat Analyzer  
  Abnoosian A, Maguire G, Annals of Clinical Psychiatry, 1/1/2008
• Orally disintegrating olanzapine and potential differences in treatment-emergent weight gain  
  Karagianis J, Hoffman VP, Arranz B, Treur T, Maguire GA, de Haan L, Chawla B, Human Psychopharmacology, 1/1/2008
• Case Report of Aripiprazole for Persistent Developmental Stuttering  
  Tran NL, Maguire GA, Franklin DL, Riley GD, Journal of Clinical Psychopharmacology, 1/1/2008
• Improvement in Hypreprolactinemia and Reproductive Comorbidities in Patients with Schizophrenia switched from Conventional Antipsychotics or Risperidone to Olanzapine  
  Kinon BJ, Ahl J, Liu-Seifert H, Maguire GA, Psychoneuroendocrinology, 1/16/2006
• Subjective Screening of Stuttering severity, locus of control and avoidance: research edition  
  Riley J, Riley G, Maguire G, Journal of Fluency Disorders, 1/1/2004
• Alleviating Stuttering through Pharmacologic Interventions  
  Maguire GA, Riley GD, Yu BP, Franklin DL, Expert Opinions in Pharmacotherapy, 1/1/2004
• QTc Prolongation Associated with Quetiapine Overdose  
  Kurth J, Maguire G, Annals of Clinical Psychiatry, 1/1/2004
• Olanzapine in the Treatment of Adult Developmental Stuttering: A Double-Blind, Placebo-Controlled Trial  
  Maguire GA, Riley GD, Franklin DL, Maguire ME, Nguyen CT, Brojeni PH, Annals of Clinical Psychiatry, 1/1/2004
• Optimal dosing of medications (in bipolar disorder)  
  Maguire GA, Phillips G, Journal of Family Practice, 1/1/2003
• Olanzapine vs Haloperidol in Geriatric Schizophrenia: Analysis of Data from a Double-blind Controlled Trial  
  Kennedy JS, Jeste D, Kaiser CJ, Golshan S, Maguire GA, Tollefson G, Sanger T, Bymaster FP, Kinon BJ, Dossenbach M, Gilmore JA, Breier A, International Journal of Geriatric Psychiatry, 1/1/2003
• Memory for Emotional Stimuli in Patients with Alzheimer’s Disease  
  Fleming K, Kim S, Doo M, Maguire G, Potkin S, Am Journal of Alzheimer’s Disease and Other Dementias, 1/1/2003
• Effectiveness of Rapid Initial Dose Escalation of up to Forty milligrams per day of oral Olanzapine in Acute Agitation  
  Baker RW, Kinon BJ, Maguire GA, Liu H, Hill AL, Journal of Clinical Psychopharmacology, 1/1/2003
• Is Generic Fluoxetine Effective?  
  Yu BP, Chong YS, Maguire GA, Journal of Affective Disorders, 1/1/2003
• Prolactin Elevation with Antipsychotic Medications: Mechanisms of Action and Clinical Consequences  
  Maguire GA, Journal of Clinical Psychiatry, 1/1/2002
• Join now to see all

Books/Book Chapters

• Without Hesitation: Speaking to the Silence and Science of Stuttering. 
  Maguire G with Wither LNSA Press2010
• Treatment of Stuttering: Established and Emerging Approaches. 
  Chapter: The Physiological Basis and Pharmacologic Treatment of Stuttering 
  Maguire GA, Riley G, Franklin DL, Gumusaneli EOEditors: Guitar, B. and McCauley, R.Lippincott, Williams & Wilkins, Baltimore, MD2009
• Speech Production: Motor Control, Brain Research and Fluency Disorders. 
  Chapter: PET Scan Evidence of Parallel Cerebral Systems Related to Treatment Effects. 
  Page 321 - 327Riley G, Wu J, Maguire GEditors: W. Hulstijn, H.F.M Peters and P.H. H. M. Van Lieshout.Elsevier Science1997
• Speech Production: Motor Control, Brain Research and Fluency Disorders. 
  Chapter: PET Scan Evidence of Parallel Cerebral Systems Related to Treatment Effects: FDG and FDOPA PET Scan Findings. 
  Page 329 - 339Wu JC, Riley G, Maguire G, Najafi A, Tang CEditors: W. Hulstijn, H.F.M Peters and P.H. H. M. Van Lieshout.Elsevier Science1997
• Speech Production: Motor Control, Brain Research and Fluency Disorders. 
  Chapter: Risperidone Treatment of Stuttering. 
  Page 379 - 382Maguire G, Riley G, Wu J, Franklin D, and Potkin SEditors: W. Hulstijn, H.F.M Peters and P.H. H. M. Van Lieshout.Elsevier Science1997
• Join now to see all

Abstracts/Posters

• Factors Associated with Weight Change in a 16-week Randomized Double-Blind, Double-dummy Trial of Sublingual Orally Disintegrating Olanzapine vs. Standard Olanzapine T...
  Maguire GA with Karagianis J, Landry J, Reed V, Hoffmann VP, Grossman L, Maguire G, Milev R, de Haan L, Institute of Psychiatric Services, 1/9/2009

Lectures

• Pharmacogenomics in Clinical Practice. 
  Los Angeles, CA - 1/31/2015
• A Review of the Challenges of Treating Bipolar Depression. 
  New York, NY - 1/3/2014
• Deep Brain Stimulation for the Treatment of OCD with Implications for Improvement in Developmental Stuttering. 
  New York, NY - 1/3/2014
• Pharmacogenomic Testing to Illustrate Unique Response to Opiates in Refractory Depression. 
  New York, NY - 1/3/2014
• Ultrasound Guidance of Olanzapine Long-Acting Injectable to Aid in Administration Accuracy. 
  New York, NY - 1/3/2014
• Treatment of Psychiatric Disorders in the Primary Care Setting. 
  Doctors Hospital at Renaissance, McAllen, TX - 1/1/2014
• The Neurophysiology and Biologic Treatment of Stuttering. 
  University of Santo Tomas, Manila, Philippines - 1/25/2013
• Understanding DSM 5 Criteria of Bipolar Mixed. 
  National University Medical Centre, Kuala Lumpur, Malaysia - 1/22/2013
• Meeting the Unmet Needs in the Mixed State of Bipolar Disorder. 
  University Malaya Medical Centre, Kuala Lumpur, Malaysia - 1/21/2013
• Acute, Atypical Psychosis Suggestive of Temporal Lobe Epilepsy Following Single Injection of Diphenhydramine and Prednisolone. 
  San Francisco, CA - 1/18/2013
• New Knowledge in the Research and Treatment of Stuttering. 
  Taipei Medical University, Taipei, Taiwan - 1/18/2013
• Update on the Pharmacologic and Biologic Treatments of Stuttering. 
  Lunteren, The Netherlands - 1/10/2013
• The Development of a Computerized LCME Dashboard to Facilitate the Self Study Process. 
  Irvine, CA - 1/6/2013
• The Feasibility of Standards-Based Technology Infrastructure for International Collaboration in Medical Education. 
  Irvine, CA - 1/5/2013
• Research Update in Stuttering. 
  Scottsdale, AZ - 1/4/2013
• The Neurophysiology and Medical Treatment of Stuttering. 
  Doctors Hospital at Renaissance, McAllen, TX - 1/2/2013
• Novel Treatment Strategies in Bipolar Disorder and Schizophrenia. 
  Manila, Philippines - 1/26/2012
• Management and Treatment of Stuttering. 
  Changi General Hospital, Singapore - 1/24/2012
• Advancements in the Treatment of Bipolar Disorder. 
  Institute of Mental Health, Singapore - 1/24/2012
• Updates on the Diagnosis and Treatment of Stuttering. 
  National University Singapore Hospital, Singapore - 1/23/2012
• Training of Psychiatry Residents. 
  Post-Graduate Medical Institute, Singapore General Hospital, Singapore - 1/23/2012
• New Knowledge in Bipolar Disorder and Advancements in Treatment. 
  Singapore - 1/20/2012
• What’s New and What’s True—Advancements in the Pharmacologic Treatment of Stuttering. 
  Melbourne, Victoria, Australia - 1/19/2012
• The Challenge of Schizophrenia: Translating Scientific Knowledge into Clinical Solutions. 
  San Diego, CA - 1/10/2012
• Understanding Psychiatric Medications in the Treatment of Stuttering. 
  Tampa, FL - 1/6/2012
• Join now to see all

Other

• Cardiac Safety of Novel Antipsychotic Medications. 
  Maguire GA, Journal of Clinical Psychiatry, CME audiograph
  1/1/2001
• Treatment of Psychosis in the Acute Care Setting. 
  Maguire GA, PsychLink, a national CME program
  1/1/2000